Guidance

Typhoid Vi vaccine: patient group direction

PGD template to support the provision of typhoid Vi polysaccharide vaccine to overseas travellers.

• From: UK Health Security Agency
• Published: 23 February 2018
• Last updated: 30 January 2024 — See all updates

Applies to England

Documents

Typhoid Vi vaccine: patient group direction

Ref: UKHSA gateway number GOV-15879

MS Word Document, 135 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of typhoid Vi polysaccharide vaccine to overseas travellers at risk of exposure to Salmonella enterica serovar typhi (S. typhi) in accordance with recommendations from the National Travel Health Network and Centre (NaTHNaC).

Typhoid Vi vaccine PGD version 4.00 is valid from 29 February 2024 to 28 February 2027.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).

Practitioners should follow local policy and procedures to access authorised PGD documents. This PGD template should be used with reference to current national guidance, Green Book, and Summary of Product Characteristics for the vaccine.

Published 23 February 2018
Last updated 30 January 2024 + show all updates

1. 30 January 2024

   Added version 4.00 - see page 2 for change history.

2. 21 February 2022

   Added v03.00.

3. 28 January 2020

   Added V02.00: routine review.

4. 23 February 2018

   First published.